Biologically active analogues of arginine vasopressin containing conformationally restricted dipeptide fragments

Journal of Peptide Research

Volumn 51, Issue 2, 1998, Pages 149-154

  Lammek, Bernard ^a   Czaja, Małgorzata ^a   Derdowska, Izabela ^a   Łempicka, Elzbieta ^a   Sikora, Piotr ^b   Szkróbka, Witold ^b   Trzeciak, Henryk I ^b  

^a UNIVERSITY OF GDA SK   (Poland)

^b MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Arginine vasopressin (AVP); Conformational constraints; V1 antagonists

Indexed keywords

ARGIPRESSIN; ARGIPRESSIN DERIVATIVE; DIPEPTIDE; OXYTOCIN RECEPTOR; VASOPRESSIN RECEPTOR ANTAGONIST; VASOPRESSIN V1 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; DIURESIS; DRUG DESIGN; DRUG POTENCY; DRUG SYNTHESIS; HORMONE RECEPTOR INTERACTION; HORMONE SYNTHESIS; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0031939551     PISSN: 1397002X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3011.1998.tb00633.x     Document Type: Article

References (25)

1. Manning, M., Przybylski, J., Olma, A., Kliś, W., Kruszyński, M., Wo, N. Co, Pelton, G.H. & Sawyer, W.H. (1987) Nature (Lond.) 329, 839
2. Lammek, B., Konieczna, E.,. Kozlowski, A., Szymkowiak, J., Trzeciak, H.I., Stojko, R. & Kupryszewski, G. (1996) J. Pharm. Pharmacol. 48, 318
3. Toniolo, C. (1990) Int. J. Pept. Protein Res. 35, 287
4. Di Maio, J.& Belleau, B. (1989) J. Chem. Soc., Perkin Trans. 1, 1687
5. Schoenberg, L.N., Cook, D.W. & Liu, C.F. (1968) Inorg. Chem. 7, 2386
6. Yamashita, T., Takenaka H. & Kojima, Y. (1993) Amino Acids 4, 187
7. Wunsch, E. & Wendlberger, B. (1964) Berichte 97, 2504
8. Manning, M. (1968) J. Am. Chem. Soc. 90, 1348
9. Lammek, B., Rekowski, P., Kupryszewski, G., Melin, P. & Ragnarsson, U. (1988) J. Med. Chem. 31, 603
10. Gisin, B.F. (1973) Helv. Chim. Acta 56, 1476
11. Köning, W. & Geiger R. (1970) Chem. Ber. 103, 788
12. Kaiser, E., Colescott, R.L., Bossinger, C.D. & Cook, P. (1970) Anal. Biochem. 34, 595
13. Christensen, T.Ch. (1979) Peptides, Structure and Biological Function (Gross, E., Meienhofer, J., eds.), p. 385, Pierce Chemical Company, Rockford, Illinois
14. Dekanski, J. (1952) Br. J. Pharmacol. 7, 567
15. Stürmer, F. (1968) Handbook of Experimental Pharmacology, p. 130, Springer Verlag, Heidelberg
16. Sawyer, W.H. (1958) Endocrinology 66, 451
17. Feder, P.I., Hobson, D.W., Olson, C.T., Joiner, R.L. & Mathews, M.C. (1991) Neurosci. Biobehav. Rev. 15, 109
18. Schild, H.B. (1947) Br. J. Pharmacol. 2, 189.
19. Manning, M. & Sawyer, W.H. (1985) in Vasopressin (Schrier, R.W., ed.), p. 131, Raven Press, New York
20. Holton, P. (1948) Br. J. Pharmacol. 3, 328
21. Munsick, P.A., (1960) Endocrinology 66, 451
22. Tallarida, R.J. & Murray, R.B. (1987) Manual of Pharmacological Calculations, Springer Verlag, Heidelberg
23. Prochazka, Z., Ancans, J.E., Slaninova, J., Machova, A., Barth, T. & Lebl, M. (1990) Collect. Czech. Chem. Commun. 55, 1099
24. Kruszyñski, M., Lammek, B., Manning, M., Seto, J., Haldar, J. & Sawyer, W.H. (1980) J. Med. Chem. 23, 364
25. Manning, M., Klis, W.A., Olma, A., Seto, J. & Sawyer, W.H. (1982) J. Med. Chem. 25, 414